this post was submitted on 01 Nov 2025
18 points (100.0% liked)

news

212 readers
767 users here now

A lightweight news hub to help decentralize the fediverse load: mirror and discuss headlines here so the giant instance communities aren’t a single choke-point.

Rules:

  1. Recent news articles only (past 30 days)
  2. Title must match the headline or neutrally describe the content
  3. Avoid duplicates & spam (search before posting; batch minor updates).
  4. Be civil; no hate or personal attacks.
  5. No link shorteners
  6. No entire article in the post body

founded 2 months ago
MODERATORS
top 3 comments
sorted by: hot top controversial new old
[–] Darkard@lemmy.world 11 points 1 day ago* (last edited 1 day ago) (1 children)

In the month since Food and Drug Administration Commissioner Marty Makary promoted the decades-old drug from GSK,

That's as far as I needed to read. GlaxoSmithKline pushed a few dollars into Marty's hands and now they get to see a spike in profit. That's all this is, another grift. Same as invermectin, same as every other drug that they promote.

Mouth breathing MAGAs who do and don't trust experts, and who will and won't put anything strange in thier bodies, and who do and don't just follow what the media says like sheep.

Pathetic

[–] prole@lemmy.blahaj.zone 4 points 1 day ago

The same people who decry vaccines because of big pharma

[–] CubitOom 9 points 1 day ago

Leucovorin is approved to treat chemotherapy side effects but can be prescribed off-label for autism symptoms.

"It puts physicians in a very tough position because they're being asked to prescribe something that is not evidence-based," said Dr. Shafali Jeste, an autism expert and head of pediatrics at UCLA, who does not prescribe leucovorin despite repeated requests.